标题
Targeted Therapies for Autoimmune Bullous Diseases: Current Status
作者
关键词
-
出版物
DRUGS
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-20
DOI
10.1007/s40265-018-0976-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Treatment of Autoimmune Bullous Disorders in Pregnancy
- (2018) Carolyn J. Kushner et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita
- (2018) C. Prost-Squarcioni et al. BRITISH JOURNAL OF DERMATOLOGY
- A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway
- (2018) Johann Bartko et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches
- (2018) Robert Pollmann et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Pemphigus group: overview, epidemiology, mortality, and comorbidities
- (2018) Khalaf Kridin IMMUNOLOGIC RESEARCH
- Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review
- (2018) Soheil Tavakolpour et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid
- (2018) Alyson V. Ridpath et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid
- (2018) Lan Lin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus
- (2018) Volker Spindler et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increasing the Complement of Therapeutic Options in Bullous Pemphigoid
- (2018) Carolyn J. Kushner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies
- (2018) Anika Kasprick et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center
- (2018) Keshavamurthy Vinay et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comment on “Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis”
- (2018) Maglie Roberto et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts
- (2018) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab
- (2018) Marwah Adly Saleh JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association of serious infections with pemphigus and pemphigoid: analysis of the Nationwide Inpatient Sample
- (2018) Z. Ren et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Diagnosis of anti-laminin γ-1 pemphigoid by immunoblot analysis
- (2018) Farzan Solimani et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Association Between Pemphigus and Neurologic Diseases
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Coexistent Solid Malignancies in Pemphigus
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
- (2018) Aniek Lamberts et al. Frontiers in Immunology
- Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes
- (2018) Khalaf Kridin et al. JAMA Dermatology
- Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study
- (2017) Caiyun You et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid
- (2017) Masayuki Amagai et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Desmoglein 3-Reactive B Cells “Hiding” in Pemphigus Lesions
- (2017) Hayato Takahashi JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis
- (2017) Huijie Yuan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016
- (2017) Enno Schmidt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Venous thromboembolism in patients with pemphigus: A cohort study
- (2017) Yael Anne Leshem et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab
- (2017) Lauren N. Albers et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis
- (2017) Lihi Atzmony et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab
- (2017) C. Baykal et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
- (2017) Pascal Joly et al. LANCET
- Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers
- (2017) Manuel Valdebran et al. JAMA Dermatology
- Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid
- (2017) Laura Sowerby et al. JAMA Dermatology
- Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity
- (2017) Nina van Beek et al. JAMA Dermatology
- Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion
- (2017) Mayumi Kamaguchi et al. Frontiers in Immunology
- A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: IsHLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
- (2017) K. T. Amber et al. HLA
- Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome
- (2017) Delphine Giusti et al. Scientific Reports
- Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.
- (2016) Z. Ren et al. BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus
- (2016) Soheil Tavakolpour Dermatologic Therapy
- APRIL levels are associated with disease activity in human chronic graft-versus-host disease
- (2016) F. Chasset et al. HAEMATOLOGICA
- First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up
- (2016) A. Razzaque Ahmed et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- High serum APRIL levels strongly correlate with disease severity in pediatric atopic eczema
- (2016) Mohamed H. Mohamed Ezzat et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Long-term results of rituximab–intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy
- (2016) Ayse Oktem et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Increase of interleukin-10-producing B cells associated with long-term remission after i.v. immunoglobulin treatment for pemphigus
- (2016) Miho Kabuto et al. JOURNAL OF DERMATOLOGY
- Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP)
- (2016) Alexander Maley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pemphigoid gestationis: a successful preventive treatment by rituximab
- (2016) M. Tourte et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature
- (2016) G. Balakirski et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- Increased risk of venous thromboembolism in patients with bullous pemphigoid
- (2016) Paolo Bucciarelli et al. THROMBOSIS AND HAEMOSTASIS
- APRIL levels are associated with disease activity in human chronic graft-versus-host disease
- (2016) F. Chasset et al. HAEMATOLOGICA
- Costs of Care for Hospitalization for Pemphigus in the United States
- (2016) Derek Hsu et al. JAMA Dermatology
- Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens
- (2015) H Wang et al. ACTA DERMATO-VENEREOLOGICA
- Novel Targeted Therapies for Eosinophil-Associated Diseases and Allergy
- (2015) Susanne Radonjic-Hoesli et al. Annual Review of Pharmacology and Toxicology
- Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid
- (2015) Michael Mersmann et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
- (2015) C. Feliciani et al. BRITISH JOURNAL OF DERMATOLOGY
- Pemphigus and associated comorbidities: a cross-sectional study
- (2015) K. Heelan et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid
- (2015) Kelly N. Messingham et al. EXPERIMENTAL DERMATOLOGY
- Rituximab preserves vision in ocular mucous membrane pemphigoid
- (2015) Anne Rübsam et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pemphigoiderkrankungen
- (2015) O.N. Horváth et al. HAUTARZT
- Pemphigus
- (2015) R. Eming HAUTARZT
- Molekulare Diagnostik der blasenbildenden Autoimmundermatosen
- (2015) K. Hoffmann et al. HAUTARZT
- Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris
- (2015) R. Asothai et al. IMMUNOBIOLOGY
- Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis
- (2015) Tegan Nguyen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris
- (2015) Yumay Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab
- (2015) Kara Heelan et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- In vivo analysis of IgE autoantibodies in bullous pemphigoid: A study of 100 cases
- (2015) Reine Moriuchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata
- (2015) Yu-Mei Han et al. JOURNAL OF DERMATOLOGY
- Effects of Intravenous Immunoglobulins on Mice with Experimental Epidermolysis Bullosa Acquisita
- (2015) Misa Hirose et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
- (2015) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin-332 IgG with oropharyngeal involvement and the usefulness of ELISA
- (2015) K.T. Amber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-Term Remissions in Recalcitrant Pemphigus Vulgaris
- (2015) A. Razzaque Ahmed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
- (2015) Nathaniel Washburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs
- (2015) Benjamin M. Fiebiger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune response in pemphigus and beyond: progresses and emerging concepts
- (2015) Giovanni Di Zenzo et al. Seminars in Immunopathology
- Successful Treatment of Mucous Membrane Pemphigoid with the Anti-CD-20 Antibody Rituximab
- (2014) T Schumann et al. ACTA DERMATO-VENEREOLOGICA
- Remission of Bullous Pemphigoid after Rituximab Treatment in a Psoriasis Patient on Regular Low-dose Methotrexate
- (2014) T Wang et al. ACTA DERMATO-VENEREOLOGICA
- Molecular Diagnosis in Autoimmune Skin Blistering Conditions
- (2014) J.V. Otten et al. CURRENT MOLECULAR MEDICINE
- Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins
- (2014) Jana Langenhan et al. EXPERIMENTAL DERMATOLOGY
- B-cell activating factor detected on both naïve and memory B cells in bullous pemphigoid
- (2014) Hua Qian et al. EXPERIMENTAL DERMATOLOGY
- A population-based study of the association between bullous pemphigoid and neurologic disorders
- (2014) Katherine E. Brick et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Omalizumab therapy for bullous pemphigoid
- (2014) Kenneth K. Yu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of bullous pemphigoid with adjuvant immunoadsorption: A case series
- (2014) Michael Kasperkiewicz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
- (2014) K.T. Amber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid
- (2014) A. Tedeschi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Type I and type II Fc receptors regulate innate and adaptive immunity
- (2014) Andrew Pincetic et al. NATURE IMMUNOLOGY
- Human Eosinophils Express the High Affinity IgE Receptor, FcεRI, in Bullous Pemphigoid
- (2014) Kelly N. Messingham et al. PLoS One
- Expression of TNF-α, April and BCMA in Behcet’s Disease
- (2014) Olfat G. Shaker et al. Journal of Immunology Research
- Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells
- (2013) A. S. W. Tjon et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris
- (2013) Kyle T. Amber et al. EXPERIMENTAL DERMATOLOGY
- Differential expression of BAFF and its receptors in discoid lupus erythematosus patients
- (2013) Benjamin F. Chong et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Intravenous Gammaglobulin Inhibits Encephalitogenic Potential of Pathogenic T Cells and Interferes with their Trafficking to the Central Nervous System, Implicating Sphingosine-1 Phosphate Receptor 1-Mammalian Target of Rapamycin Axis
- (2013) S. Othy et al. JOURNAL OF IMMUNOLOGY
- Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
- (2013) Russell P. Hall et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication
- (2013) M. Kolesnik et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- General mechanism for modulating immunoglobulin effector function
- (2013) P. Sondermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity
- (2013) Ikuko Ueda-Hayakawa et al. RHEUMATOLOGY
- Detection of IgG and IgE reactivity to BP180 using the ISAC®microarray system
- (2012) D. Pomponi et al. BRITISH JOURNAL OF DERMATOLOGY
- Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease
- (2012) A. V. Marzano et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses
- (2012) Luca Fania et al. CLINICAL IMMUNOLOGY
- IVIg-mediated inhibition of antigen presentation: Predominant role of naturally occurring cationic IgG
- (2012) Patrick Trépanier et al. CLINICAL IMMUNOLOGY
- Adjuvant Treatment of Recalcitrant Bullous Pemphigoid with Immunoadsorption
- (2012) P.A. Müller et al. DERMATOLOGY
- Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models
- (2012) Hideyuki Ujiie et al. EXPERIMENTAL DERMATOLOGY
- Functional Characterization of an IgE-Class Monoclonal Antibody Specific for the Bullous Pemphigoid Autoantigen, BP180
- (2012) Kelly A.N. Messingham et al. HYBRIDOMA
- In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity
- (2012) Leslie P. Cousens et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Inhibitory Effect of IVIG on IL-17 Production by Th17 Cells is Independent of Anti-IL-17 Antibodies in the Immunoglobulin Preparations
- (2012) Mohan S. Maddur et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site
- (2012) Osamu Fukuchi et al. JOURNAL OF DERMATOLOGY
- The expression of BAFF in the muscles of patients with dermatomyositis
- (2012) Ahmi Baek et al. JOURNAL OF NEUROIMMUNOLOGY
- A Case of Recalcitrant Epidermolysis Bullosa Acquisita Responsive to Rituximab Therapy
- (2012) Sophia K. McKinley et al. PEDIATRIC DERMATOLOGY
- Immunoadsorption in Dermatology
- (2012) Damian Meyersburg et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Targeting B Cells and Antibody in Transplantation
- (2011) M. R. Clatworthy AMERICAN JOURNAL OF TRANSPLANTATION
- Rituximab for Severe Mucous Membrane Pemphigoid
- (2011) Michael Hertl ARCHIVES OF DERMATOLOGY
- Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis
- (2011) S. Yayli et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients
- (2011) M. Kasperkiewicz et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy
- (2011) R.J. Feldman et al. BRITISH JOURNAL OF DERMATOLOGY
- Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris
- (2011) M. Behzad et al. BRITISH JOURNAL OF DERMATOLOGY
- Low-dose rituximab is effective in pemphigus
- (2011) B. Horváth et al. BRITISH JOURNAL OF DERMATOLOGY
- Pemphigoid Gestationis: Current Management
- (2011) Lizbeth R.A. Intong et al. DERMATOLOGIC CLINICS
- Lesional Th17 cells and regulatory T cells in bullous pemphigoid
- (2011) Masataka Arakawa et al. EXPERIMENTAL DERMATOLOGY
- Therapieresistentes Anti-Laminin-332-Schleimhautpemphigoid
- (2011) A. Recke et al. HAUTARZT
- Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris
- (2011) T. Yokoyama et al. INTERNATIONAL IMMUNOLOGY
- Eosinophil extracellular DNA traps in skin diseases
- (2011) Dagmar Simon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Glucocorticosteroid-resistant pemphigoid gestationis: Successful treatment with adjuvant immunoadsorption
- (2011) Lilia WESTERMANN et al. JOURNAL OF DERMATOLOGY
- Successful treatment of epidermolysis bullosa acquisita with rituximab therapy
- (2011) Jong Hoon KIM et al. JOURNAL OF DERMATOLOGY
- Dominant Th2 Differentiation of Human Regulatory T Cells upon Loss of FOXP3 Expression
- (2011) L. Hansmann et al. JOURNAL OF IMMUNOLOGY
- FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid
- (2011) K. N. Messingham et al. JOURNAL OF IMMUNOLOGY
- Enhancement of the Affinity of Glucocorticoid Receptors as a Mechanism Underlying the Steroid-sparing Effect of Intravenous Immunoglobulin: Figure 1.
- (2011) ANASTAS PASHOV et al. JOURNAL OF RHEUMATOLOGY
- Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients
- (2011) Michael Kasperkiewicz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
- (2011) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up
- (2011) A.R. Ahmed et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Immunoadsorption in dermatology
- (2010) Enno Schmidt et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms
- (2010) Masato Watanabe et al. CYTOKINE & GROWTH FACTOR REVIEWS
- sHLA-I Contamination, A Novel Mechanism to Explain Ex Vivo/In Vitro Modulation of IL-10 Synthesis and Release in CD8+ T Lymphocytes and in Neutrophils Following Intravenous Immunoglobulin Infusion
- (2010) Massimo Ghio et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies
- (2010) Margarita Lolis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease
- (2010) Yaohan Li et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients
- (2010) S. Lourari et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris
- (2010) A.R. Ahmed et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Combination of Rituximab and Intravenous Immunoglobulin for Recalcitrant Ocular Cicatricial Pemphigoid
- (2010) C. Stephen Foster et al. OPHTHALMOLOGY
- Intravenous Immunoglobulins Promote Skin Allograft Acceptance by Triggering Functional Activation of CD4+Foxp3+ T cells
- (2010) Thanyalak Tha-In et al. TRANSPLANTATION
- Efficacité du rituximab dans une pemphigoïde bulleuse en échec thérapeutique
- (2009) Z. Reguiaï et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Rituximab in Severe Pemphigus
- (2009) Enno Schmidt et al. Annals of the New York Academy of Sciences
- Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
- (2009) Ji Yang et al. ARTHRITIS AND RHEUMATISM
- Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation
- (2009) E. Aubin et al. BLOOD
- Refractory epidermolysis bullosa acquisita: successful treatment with rituximab
- (2009) M. Saha et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3
- (2009) Angela Nagel et al. CLINICAL IMMUNOLOGY
- Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
- (2009) Richard L. Wasserman et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Intravenous immunoglobulin up-regulates the expression of the inhibitory FcγIIB receptor on B cells
- (2009) Kalina A Nikolova et al. IMMUNOLOGY AND CELL BIOLOGY
- Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
- (2009) Janet A. Fairley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid
- (2009) Kelly A.N. Messingham et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris
- (2009) Angela Nagel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for pemphigus
- (2009) Masayuki Amagai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of Juvenile Pemphigus Vulgaris with Intravenous Immunoglobulin Therapy
- (2009) Adam Asarch et al. PEDIATRIC DERMATOLOGY
- Impaired inhibitory Fc receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy
- (2009) B. Tackenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Intravenous Immunoglobulin Therapy on Serum Levels of IgG1 and IgG4 Antidesmoglein 1 and Antidesmoglein 3 Antibodies in Pemphigus Vulgaris
- (2008) Michelle G. Green et al. ARCHIVES OF DERMATOLOGY
- Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: Implications for the clinical use of intravenous immunoglobulins (IVIg)
- (2008) Stephan von Gunten et al. AUTOIMMUNITY REVIEWS
- Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
- (2008) R. Stasi et al. BLOOD
- BAFF is elevated in serum of patients with psoriasis: association with disease activity
- (2008) S. Samoud-El Kissi et al. BRITISH JOURNAL OF DERMATOLOGY
- IgE autoantibodies against the intracellular domain of BP180
- (2008) S.K. Dresow et al. BRITISH JOURNAL OF DERMATOLOGY
- Rituximab: Beyond Simple B Cell Depletion
- (2008) A. Kessel et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy
- (2008) Derin B. Keskin et al. CYTOKINE
- Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases
- (2008) Michael Hertl et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Rituximab Exerts a Dual Effect in Pemphigus Vulgaris
- (2008) Rüdiger Eming et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus
- (2008) Annette Czernik et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis
- (2007) A. Ephrem et al. BLOOD
- Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid
- (2007) Nobuko Ishiura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now